KLSE:SUNMED Statistics
Total Valuation
KLSE:SUNMED has a market cap or net worth of MYR 23.93 billion. The enterprise value is 24.26 billion.
Important Dates
The last earnings date was Thursday, November 19, 2026.
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:SUNMED has 11.51 billion shares outstanding. The number of shares has decreased by -10.53% in one year.
| Current Share Class | 11.51B |
| Shares Outstanding | 11.51B |
| Shares Change (YoY) | -10.53% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 15.57% |
| Float | 3.09B |
Valuation Ratios
The trailing PE ratio is 75.10 and the forward PE ratio is 58.59. KLSE:SUNMED's PEG ratio is 2.48.
| PE Ratio | 75.10 |
| Forward PE | 58.59 |
| PS Ratio | 9.16 |
| PB Ratio | 6.93 |
| P/TBV Ratio | 7.00 |
| P/FCF Ratio | 254.49 |
| P/OCF Ratio | 49.63 |
| PEG Ratio | 2.48 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 40.70, with an EV/FCF ratio of 257.98.
| EV / Earnings | 76.05 |
| EV / Sales | 9.29 |
| EV / EBITDA | 40.70 |
| EV / EBIT | 64.59 |
| EV / FCF | 257.98 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.43.
| Current Ratio | 1.46 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 2.48 |
| Debt / FCF | 15.74 |
| Interest Coverage | 5.91 |
Financial Efficiency
Return on equity (ROE) is 10.87% and return on invested capital (ROIC) is 9.44%.
| Return on Equity (ROE) | 10.87% |
| Return on Assets (ROA) | 6.11% |
| Return on Invested Capital (ROIC) | 9.44% |
| Return on Capital Employed (ROCE) | 8.46% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.50 |
| Inventory Turnover | 9.68 |
Taxes
In the past 12 months, KLSE:SUNMED has paid 31.83 million in taxes.
| Income Tax | 31.83M |
| Effective Tax Rate | 9.07% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.11 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 45.14 |
| Average Volume (20 Days) | 7,172,420 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:SUNMED had revenue of MYR 2.61 billion and earned 319.04 million in profits. Earnings per share was 0.03.
| Revenue | 2.61B |
| Gross Profit | 1.60B |
| Operating Income | 375.62M |
| Pretax Income | 350.87M |
| Net Income | 319.04M |
| EBITDA | 579.50M |
| EBIT | 375.62M |
| Earnings Per Share (EPS) | 0.03 |
Full Income Statement Balance Sheet
The company has 1.15 billion in cash and 1.48 billion in debt, with a net cash position of -328.17 million or -0.03 per share.
| Cash & Cash Equivalents | 1.15B |
| Total Debt | 1.48B |
| Net Cash | -328.17M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 3.45B |
| Book Value Per Share | 0.30 |
| Working Capital | 589.37M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 482.25 million and capital expenditures -388.20 million, giving a free cash flow of 94.04 million.
| Operating Cash Flow | 482.25M |
| Capital Expenditures | -388.20M |
| Depreciation & Amortization | 203.87M |
| Net Borrowing | -134.43M |
| Free Cash Flow | 94.04M |
| FCF Per Share | 0.01 |
Full Cash Flow Statement Margins
Gross margin is 61.45%, with operating and profit margins of 14.38% and 12.21%.
| Gross Margin | 61.45% |
| Operating Margin | 14.38% |
| Pretax Margin | 13.43% |
| Profit Margin | 12.21% |
| EBITDA Margin | 22.19% |
| EBIT Margin | 14.38% |
| FCF Margin | 3.60% |
Dividends & Yields
KLSE:SUNMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 36.51% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 10.53% |
| Shareholder Yield | 10.53% |
| Earnings Yield | 1.33% |
| FCF Yield | 0.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside | |
Analyst Forecast
The average price target for KLSE:SUNMED is 2.05, which is -1.39% lower than the current price. The consensus rating is "Hold".
| Price Target | 2.05 |
| Price Target Difference | -1.39% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 18.31% |
| EPS Growth Forecast (3Y) | 26.05% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KLSE:SUNMED has an Altman Z-Score of 6.86 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.86 |
| Piotroski F-Score | 6 |